Skip to main content

Author: Editor

Paediatric clinical trials: single parent or both parents’ signature needed?

It is ethically recommended to obtain written consent from both parents, particularly if the study may have significant implications for the child or family. In the Informed Consent Form (ICF), two signature lines should be present.

Simultaneous signing is not required. The parent that is present at the on-site visit can take the ICF home which gives the other parent the opportunity to sign it too. Sufficient time should be given to participants and parents to consider before signing the ICF, allowing for both signatures to be obtained at a later time.

However, there may be situations where obtaining written consent from both parents is not feasible or appropriate, such as when one parent is unavailable (e.g.  when one parent is deceased, is in jail, in single-parent households,…), or estranged and there is no indication for the principal investigator (directly or indirectly) that the absent parent has a different opinion about the participation of the child in the study. In such cases, it may be ethically permissible to proceed with obtaining written consent from a single parent, provided that prior efforts have been made to involve and inform both parents and that the decision is made in the best interest of the child.

In that case, the parent that is present at the on-site visit should be asked if the co-parent would agree to the inclusion of the child in the study. If only one parent signs, it must be clear to that single parent that his/her written consent implies the consent of the other absent parent of the child/minor. It is good practice to document in the ICF that one parent signs on behalf of both parents, including the rationale behind.

If the principal investigator has knowledge of refusal of the other parent to allow the child to participate in the study, the principal investigator cannot include the child without the written consent of the other parent.

Ultimately, the ethical principle of respect for autonomy suggests that efforts should be made to obtain consent from all relevant parties whenever possible. However, it’s important to acknowledge that there are circumstances where both parents are not available. In such cases, it’s crucial to recognize that the remaining parent signs in their own capacity, not on behalf of both parents.

It’s essential to approach these situations with sensitivity and ensure that decisions are made in the best interest of the child.

Compensation contraception

BAREC wishes to provide clear guidance on the reimbursement of contraception-related expenses in the context of clinical trials, emphasizing the principle that sponsors should cover these costs when a participant is required to use contraception as part of the study protocol.

Continue reading

BAREC statement race and ethnicity

The participants in a clinical trial should reflect the target population. Adequate reporting of race and ethnicity can potentially contribute to better understanding of cultural, social, and biological differences, enabling the identification of population groups disproportionately affected by certain diseases, along with genetic information collected from study participants.

Continue reading

BAREC SYMPOSIUM 09 December 2023

Belgian Association of Research Ethics Committees (BAREC)

SYMPOSIUM 09 December 2023, The Royal Library of Belgium, Brussels



If you would like to read more about this, please consider becoming a Barec-member and acquire access to our member area.
Please contact us for more information on becoming a member via:


Ethics is not mathematics

About the necessity for Harmonisation of the assessments for clinical research CTR/MDR/IVDR

Please register here before 04 December 2023



9:00 – 9:20: Registration and welcome coffee


Morning sessions for all stakeholders

 9:20 – 9:30: Welcome word by the president of BAREC (Christel Vansteenkiste)

9:30 – 9:45: The messiness of research ethics (Bert Vanderhaegen)

9:45 – 10:05: Point of view of CT-College

10:05 – 10:25: Point of view of FAHMP

10:25 – 10:45: Point of view of sponsor


10:45 – 11:15: Coffee break


11:15 – 11:30: Point of view of an Ethics Committee (Minne Casteels)

11:30 – 11:45: A national EC or harmonisation and education, the better solution? (Audrey Van Scharen)

11:45 – 12:30: Panel discussion


12:30 – 13:30: Lunch


Afternoon session for Ethics Committees

 13:30 – 16:00: Reflecting on the morning’s insights: A Panel Discussion on the presented information



EC members

–          Without lunch €20

–          With lunch €50


Non-EC members

–          Without lunch €50

–          With lunch €80


Please make a payment to the following bank account number: BE35 0689 3066 7537

RIZIV/INAMI Accreditation for Ethics Requested